Cargando…
Mechanisms of resistance to immune checkpoint inhibitors and strategies to reverse drug resistance in lung cancer
In recent years, the research of immune checkpoint inhibitors has made a great breakthrough in lung cancer treatment. Currently, a variety of immune checkpoint inhibitors have been applied into clinical practice, including antibodies targeting the programmed cell death-1, programmed cell death-ligan...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575183/ https://www.ncbi.nlm.nih.gov/pubmed/32969861 http://dx.doi.org/10.1097/CM9.0000000000001124 |